» Articles » PMID: 20430263

Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results from 588,398 Procedures in the National Cardiovascular Data Registry

Abstract

Objectives: We sought to create contemporary models for predicting mortality risk following percutaneous coronary intervention (PCI).

Background: There is a need to identify PCI risk factors and accurately quantify procedural risks to facilitate comparative effectiveness research, provider comparisons, and informed patient decision making.

Methods: Data from 181,775 procedures performed from January 2004 to March 2006 were used to develop risk models based on pre-procedural and/or angiographic factors using logistic regression. These models were independently evaluated in 2 validation cohorts: contemporary (n = 121,183, January 2004 to March 2006) and prospective (n = 285,440, March 2006 to March 2007).

Results: Overall, PCI in-hospital mortality was 1.27%, ranging from 0.65% in elective PCI to 4.81% in ST-segment elevation myocardial infarction patients. Multiple pre-procedural clinical factors were significantly associated with in-hospital mortality. Angiographic variables provided only modest incremental information to pre-procedural risk assessments. The overall National Cardiovascular Data Registry (NCDR) model, as well as a simplified NCDR risk score (based on 8 key pre-procedure factors), had excellent discrimination (c-index: 0.93 and 0.91, respectively). Discrimination and calibration of both risk tools were retained among specific patient subgroups, in the validation samples, and when used to estimate 30-day mortality rates among Medicare patients.

Conclusions: Risks for early mortality following PCI can be accurately predicted in contemporary practice. Incorporation of such risk tools should facilitate research, clinical decisions, and policy applications.

Citing Articles

Machine learning-driven prediction of medical expenses in triple-vessel PCI patients using feature selection.

Chen K, Huang Y, Liu C, Li S, Chen M BMC Health Serv Res. 2025; 25(1):105.

PMID: 39833782 PMC: 11744989. DOI: 10.1186/s12913-025-12218-6.


Institution of a formal multidisciplinary heart team for high-risk coronary revascularization.

Potluri S, Sawhney R, Dorton C, McCullough K, Moubarak G, Shih E Proc (Bayl Univ Med Cent). 2024; 38(1):28-33.

PMID: 39712420 PMC: 11657062. DOI: 10.1080/08998280.2024.2426925.


Validation of EuroSCORE II, ACEF Score, CHADS-VASc, and CHADS-VA in Patients Undergoing Left Main Coronary Artery Angioplasty: Analysis from All-Comers BIA-LM Registry.

Dabrowski E, Kralisz P, Nowak K, Gugala K, Prokopczuk P, Mezynski G J Clin Med. 2024; 13(22).

PMID: 39598051 PMC: 11595233. DOI: 10.3390/jcm13226907.


Should We Use Aspirin or P2Y Inhibitor Monotherapy in Stable Ischemic Heart Disease?.

Chandiramani R, Mehta A, Blumenthal R, Williams M Curr Atheroscler Rep. 2024; 26(11):649-658.

PMID: 39243345 DOI: 10.1007/s11883-024-01234-2.


Assessing Quality in Interventional Practice: Identifying Meaningful and Actionable Metrics.

Klein L Rev Cardiovasc Med. 2024; 25(2):58.

PMID: 39077330 PMC: 11263148. DOI: 10.31083/j.rcm2502058.


References
1.
Rihal C, Grill D, Bell M, Berger P, Garratt K, Holmes Jr D . Prediction of death after percutaneous coronary interventional procedures. Am Heart J. 2000; 139(6):1032-8. DOI: 10.1067/mhj.2000.105299. View

2.
Addala S, Grines C, Dixon S, Stone G, Boura J, Ochoa A . Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol. 2004; 93(5):629-32. DOI: 10.1016/j.amjcard.2003.11.036. View

3.
Singh M, Rihal C, Gersh B, Roger V, Bell M, Lennon R . Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol. 2008; 51(24):2313-20. PMC: 2733245. DOI: 10.1016/j.jacc.2008.01.066. View

4.
Wennberg D, Makenka D, Sengupta A, Lucas F, Vaitkus P, Quinton H . Percutaneous transluminal coronary angioplasty in the elderly: epidemiology, clinical risk factors, and in-hospital outcomes. The Northern New England Cardiovascular Disease Study Group. Am Heart J. 1999; 137(4 Pt 1):639-45. DOI: 10.1016/s0002-8703(99)70216-4. View

5.
Feldman T, Hirshfeld Jr J, Kern M, King 3rd S, Morrison D, ONeill W . ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for.... J Am Coll Cardiol. 2006; 47(1):e1-121. DOI: 10.1016/j.jacc.2005.12.001. View